mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |